Visiomed Group S.A.

As of December 31, 2023, Visiomed Group S.A. has 294.17M shares outstanding.

As of December 31, 2023, Visiomed Group S.A. trades at a trailing price-to-earnings ratio of 92.35. The price-to-sales ratio is 6.08, and the price-to-book ratio stands at 21.66.

As of December 31, 2023, Visiomed Group S.A. trades at an EV/EBITDA multiple of 93.39 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 6.49 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 93.39 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Visiomed Group S.A. trades at an EV/FCF ratio of 17.95, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2023, Visiomed Group S.A. maintains a current ratio of 1.56, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.03, indicating elevated leverage, while an interest coverage ratio of 0.79 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2023. Return on assets (ROA) stands at 2.48, measuring how efficiently the asset base is converted into earnings. Inventory turnover of 22.52 indicates how many times Visiomed Group S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on July 30, 2024, Visiomed Group S.A.'s stock has declined approximately 61.23% over the past 52 weeks. The 50-day moving average sits at 0.18, while the 200-day moving average is 0.24.

Over the twelve months ended December 31, 2023, Visiomed Group S.A. posted a gross margin of 45.95, reflecting its pricing power and cost economics. The operating margin of 6.95 and net profit margin of 6.58 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2023. Free cash flow yield stands at 3.67, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.25, meaning Visiomed Group S.A. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Visiomed Group S.A.'s most recent stock split took place on March 19, 2020 with a 40:1 split ratio.

As of December 31, 2023, Visiomed Group S.A. has an Altman Z-Score of 5.97, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.